Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million
have chronic infection, and 600,000 die each year from HBV-related liver disease or …

The idea of recording information on all cancer cases in defined communities dates from the
first half of the twentieth century, and there has been a steady growth in the number of such …

Several infectious agents are considered to be causes of cancer in humans. The fraction of
the different types of cancer, and of all cancers worldwide and in different regions, has been …

A causal link between chronic inflammation and carcinogenesis is explored by reviewing
illustrative examples of specific cancers and causal agents and mechanisms. The causal …

It has been almost 25 years since Doll and Peto performed their landmark analysis of
epidemiological data to identify the causes of cancers and possible modes of cancer …

Chronic hepatitis B virus (HBV) infection affects over 350 million people worldwide and over
1 million die annually of HBV-related chronic liver disease. Although many individuals …

Chronic hepatitis B is the most common cause of hepatocellular carcinoma (HCC) in Asia.
Integration of hepatitis B virus (HBV) genome is likely an early event of carcinogenesis. The …

The national hepatitis B vaccination program in Taiwan is considered one of the most
successful and effective public health programs to control chronic hepatitis B infection in the …

This article reviews progress in chemopreventive drug development, especially data and
concepts that are new since the 2002 AACR report on treatment and prevention of …

Human liver cancer, primarily hepatocellular carcinoma (HCC), is both common and lethal.
Notable variation in HCC incidence rates worldwide corresponds to the prevalence and …